Submitted by Anonymous (not verified) on 19 January 2026 - 16:26
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 3, Status: Authorised